Search Results - "Riedhammer, Christine"

Effects of Alemtuzumab on (Auto)antigen-Specific Immune Responses by Hilger, Clara, Riedhammer, Christine, Orsó, Evelyn, Weissert, Robert

“…Alemtuzumab (anti-CD52 mAb) leads to a long-lasting disease activity suppression in patients with relapsing forms of multiple sclerosis (MS). In this study, we…”
Get full text

Venetoclax salvage therapy in relapsed/refractory multiple myeloma by Steinhardt, Maximilian J, Truger, Marietta, Bittrich, Max, Zhou, Xiang, Noderer, Julia, Riedhammer, Christine, Xiao, Xianghui, Gawlas, Sophia, Weis, Philipp, Eisele, Florian, Haferlach, Claudia, Mersi, Julia, Waldschmidt, Johannes, Einsele, Hermann, Rasche, Leo, Kortüm, K Martin

Get full text

P814: ANALYSIS OF TP53 ALTERATIONS BY WGS REVEALS BIALLELIC 17P DELETIONS IN MULTIPLE MYELOMA by Truger, Marietta, Hutter, Stephan, Walter, Wencke, Zhou, Xiang, Riedhammer, Christine, Meggendorfer, Manja, Müller, Heiko, Kern, Wolfgang, Haferlach, Torsten, Einsele, Hermann, Martin Kortum, K, Haferlach, Claudia, Rasche, Leo

Get full text

P890: COMBINING SKY92 GENE EXPRESSION PROFILING WITH CYTOGENETICS ACCORDING TO R2‐ISS FOR MULTIPLE MYELOMA RISK CLASSIFICATION: THE FIRST PROSPECTIVE EVIDENCE by Zhou, Xiang, Engel, Benedict, Hofmann, Annika, Vogt, Cornelia, Nerreter, Silvia, Teufel, Eva, Stanojkovska, Emilia, Truger, Marietta, Weis, Philipp, Xiao, Xianghui, Eisele, Florian, Riedhammer, Christine, Johannes Steinhardt, Maximilian, Munawar, Umair, Han, Seungbin, Haertle, Larissa, Haferlach, Claudia, Einsele, Hermann, Martin Kortum, K, Rasche, Leo

Get full text

Peripheral Blood Mononuclear Cells: Isolation, Freezing, Thawing, and Culture by Riedhammer, Christine, Halbritter, Dagmar, Weissert, Robert

“…The work with peripheral blood mononuclear cells (PBMCs), which comprise lymphocytes and monocytes, is indispensable in immunological diagnostics and research…”
Get more information

Antigen Presentation, Autoantigens, and Immune Regulation in Multiple Sclerosis and Other Autoimmune Diseases by Riedhammer, Christine, Weissert, Robert

“…Antigen presentation is in the center of the immune system, both in host defense against pathogens, but also when the system is unbalanced and autoimmune…”
Get full text

Taste Abnormalities Emerging during Anti-Myeloma Therapies Including GPRC5D x CD3 Bispecific Antibody Talquetamab by Fleischer, Anna, Roll, Magdalena, Panther, Franziska, Gelbrich, Goetz, Reinhardt, Franziska, Riedhammer, Christine, Mersi, Julia, Waldschmidt, Johannes M, Einsele, Hermann, Kortüm, K. Martin, Maatouk, Imad, Rasche, Leo

“…Background: Dysgeusia is a common, yet underexamined side-effect of anti-tumor therapy. In multiple myeloma (MM) it has received more attention recently with…”
Get full text

The Impact of Treatment-Free Intervals on T-Cell Exhaustion and Clonotypic Diversity in Myeloma Patients Treated with BCMA Bispecific Antibodies by Eisele, Florian, Afrin, Nazia, Stanojkovska, Emilia, John, Mara, Helal, Moutaz, Grundheber, Lars, Weis, Philipp, Riedhammer, Christine, Kadel, Sofie-Katrin, Steinhardt, Max, Duell, Johannes, Waldschmidt, Johannes M, Einsele, Hermann, Riedel, Angela, Kortüm, K. Martin, Rasche, Leo

“…Background: BCMAxCD3 bispecific antibodies (BsAb) have changed the treatment landscape in relapsed refractory multiple myeloma (RRMM). However, despite high…”
Get full text

Prolonged Cytopenia Following CAR T-Cell Therapy in Relapsed/Refractory Multiple Myeloma: A Prospective Comprehensive Biomarker Study by Zhou, Xiang, Wagner, Vivien, Stanojkovska, Emilia, Riedhammer, Christine, Xiao, Xianghui, John, Mara, Scheller, Lukas, Munawar, Umair, Han, Seungbin, Waldschmidt, Johannes M, Topp, Max S., Duell, Johannes, Einsele, Hermann, Riedel, Angela, Kortüm, Martin, Rasche, Leo

“…Background Chimeric antigen receptor (CAR) modified T-cells are leading to a paradigm shift in the treatment of relapsed/refractory (RR) multiple myeloma (MM)…”
Get full text

Safety and Efficacy of Venetoclax Salvage Therapy in Relapsed/Refractory Multiple Myeloma with and without t(11;14) by Steinhardt, Maximilian J, Bittrich, Max, Zhou, Xiang, Noderer, Julia, Riedhammer, Christine, Xiao, Xianghui, Gawlas, Sophia, Weis, Philipp, Eisele, Florian, Munawar, Umair, Han, Seungbin, Mersi, Julia, Waldschmidt, Johannes M, Einsele, Hermann, Rasche, Leo, Kortüm, K. Martin

“…Background: The BCL2 inhibitor Venetoclax (Ven) is an effective treatment option in multiple myeloma (MM). However, despite the recent inclusion in European MM…”
Get full text

Spatial Transcriptomics Reveals a Multi Cellular Ecosystem in Extramedullary Multiple Myeloma by Helal, Moutaz, John, Mara, Stanojkovska, Emilia, Mattavelli, Greta, Grundheber, Lars, Leipold, Alexander, Afrin, Nazia, Riedhammer, Christine, Duell, Johannes, Steinhardt, Max Johannes, Mersi, Julia, Einsele, Hermann, Kretzschmar, Kai, Kortuem, K. Martin, Riedel, Angela, Rasche, Leo

Get full text

Spatial transcriptomics reveals profound subclonal heterogeneity and T-cell dysfunction in extramedullary myeloma by John, Mara, Helal, Moutaz, Duell, Johannes, Mattavelli, Greta, Stanojkovska, Emilia, Afrin, Nazia, Leipold, Alexander M., Steinhardt, Maximilian J., Zhou, Xiang, Žihala, David, Anilkumar Sithara, Anjana, Mersi, Julia, Waldschmidt, Johannes M., Riedhammer, Christine, Kadel, Sofie-Katrin, Truger, Marietta, Werner, Rudolf A., Haferlach, Claudia, Einsele, Hermann, Kretzschmar, Kai, Jelínek, Tomáš, Rosenwald, Andreas, Kortüm, K. Martin, Riedel, Angela, Rasche, Leo

“…•EMD mimics the architectural complexity of solid tumors, marked by diverse microenvironments, multiclonality, and TNFRSF17 and GPRC5D levels.•EMD shows…”
Get full text

Real-World Analysis of Teclistamab in 115 RRMM Patients from Germany by Riedhammer, Christine, Bassermann, Florian, Besemer, Britta, Bewarder, Moritz, Brunner, Franziska, Carpinteiro, Alexander, Einsele, Hermann, Faltin, Josefine, Frenking, Jan, Gezer, Deniz, Goldman-Mazur, Sarah, Hanel, Mathias, Hoegner, Marion, Kortüm, K. Martin, Krönke, Jan, Kull, Miriam, Leitner, Theo, Mann, Christoph, Mecklenbrauck, Rabea, Merz, Maximilian, Morgner, Anke, Nogai, Axel, Raab, Marc S., Teipel, Raphael, Wäsch, Ralph, Rasche, Leo

“…Background Bispecific antibodies and CAR-T cells are currently changing the treatment landscape of relapsed and refractory multiple myeloma (RRMM), having…”
Get full text

Changes in T‐cell subsets, preexisting cytopenias and hyperferritinaemia correlate with cytopenias after BCMA targeted CAR T‐cell therapy in relapsed/refractory multiple myeloma: Results from a prospective comprehensive biomarker study by Zhou, Xiang, Wagner, Vivien, Scheller, Lukas, Stanojkovska, Emilia, Riedhammer, Christine, Xiao, Xianghui, Steinhardt, Maximilian Johannes, Vogt, Cornelia, Nerreter, Silvia, Eisele, Florian, John, Mara, Munawar, Umair, Kadel, Sofie‐Katrin, Mersi, Julia, Ruckdeschel, Anna, Schimanski, Sven, Haertle, Larissa, Waldschmidt, Johannes Moritz, Han, Seungbin, Topp, Max, Duell, Johannes, Einsele, Hermann, Riedel, Angela, Kortüm, K. Martin, Rasche, Leo

“…Summary Biomarkers for cytopenias following CAR T‐cell treatment in relapsed/refractory (RR) multiple myeloma (MM) are not completely defined. We prospectively…”
Get full text

Increased Immune Reactivity to Central Nervous System Derived Naturally Presented Peptides in Patients with Active Multiple Sclerosis by Riedhammer, Christine, Halbritter, Dagmar, CLT, Weissert, Robert, MD PhD

“…Because the immune response to positive control mitogen PHA and antigen tetanus toxoid and the peptide derived from tetanus toxoid did not differ between…”
Get full text

Advanced Risk Stratification in Multiple Myeloma Beyond Traditional FISH: The First Prospective Real-World Evidence for SKY92 Gene Expression Profiling by Zhou, Xiang, Hofmann, Annika, Vogt, Cornelia, Nerreter, Silvia, Teufel, Eva, Stanojkovska, Emilia, Truger, Marietta, Engel, Benedict, Barcic, Anastasia, Peter, Jessica, Riedhammer, Christine, Steinhardt, Max Johannes, Xiao, Xianghui, Hornburger, Hannah, Han, Seungbin, Haertle, Larissa, Munawar, Umair, Mersi, Julia, Haferlach, Claudia, Einsele, Hermann, Rasche, Leo, Kortuem, K. Martin

Get full text

P-417 SKY92 gene expression profiling and cytogenetics according to R2-ISS for multiple myeloma risk classification by Zhou, Xiang, Engel, Benedict, Hofmann, Annika, Vogt, Cornelia, Nerreter, Silvia, Teufel, Eva, Stanojkovska, Emilia, Truger, Marietta, Xiao, Xianghui, Riedhammer, Christine, Munawar, Umair, Han, Seungbin, Haertle, Larissa, Haferlach, Claudia, Einsele, Hermann, Rasche, Leo, Kortüm, Martin

Get full text

P-489 Prolonged cytopenia after CAR T-cell therapy in multiple myeloma: results from a prospective comprehensive biomarker study by Zhou, Xiang, Stanojkovska, Emilia, Wagner, Vivien, Riedhammer, Christine, Xiao, Xianghui, John, Mara, Munawar, Umair, Han, Seungbin, Waldschmidt, Johannes, Topp, Max, Duell, Johannes, Einsele, Hermann, Riedel, Angela, Kortüm, Martin, Rasche, Leo

Get full text

P-480 Outcome of pneumocystis jirovecii pneumonia in patients with multiple myeloma by Riedhammer, Christine, Duell, Johannes, Kestler, Christian, Kadel, Sofie, Franz, Johanna, Weis, Philipp, Eisele, Florian, Zhou, Xiang, Steinhardt, Maximilian, Scheller, Lukas, Mersi, Julia, Waldschmidt, Johannes, Einsele, Hermann, Kortüm, Martin, Turnwald, Doris, Surat, Güzin, Rasche, Leo

Get full text

OA-24 Sequential and persistent loss of BCMA and GPRC5D after bispecific antibodies in multiple myeloma revealed by whole genome sequencing by Rasche, Leo, Truger, Marietta, Munawar, Umair, Helal, Moutaz, Han, Seungbin, Zhou, Xiang, Eisele, Florian, Riedhammer, Christine, Duell, Johannes, Meggendorfer, Manja, Müller, Heiko, Waldschmidt, Johannes, Mersi, Julia, Panther, Franziska, Rosenwald, Andreas, Haferlach, Claudia, Einsele, Hermann, Kortüm, Martin

Get full text